Chemotherapy of Delirium Tremens: A Survey of Physicians' Preferences
ARMANDO B. FAVAZZA M.D., M.P.H.1, and
PATRICIA MARTIN M.B.2
1 Associate Professor, Department of Psychiatry, School of Medicine, University of Missouri-Columbia, Columbia, Mo. 65201
2 Resident, Department of Psychiatry, School of Medicine, University of Missouri-Columbia, Columbia, Mo. 65201
Because of the confusion in the literature concerning the chemotherapy of delirium tremens, the authors sent questionnaires to selected experienced physicians throughout the nation. Out of 101 useful responses, 86 physicians chose a benzodiazepine as a primary drug of choice. Of these, 64 favored chlordiazepoxide and 22 favored diazepam. The overall mortality of the patients they treated appeared to be quite low.
